Results 271 to 280 of about 65,496 (283)

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source

Dipeptidyl Peptidase-4 in Cariometabolic Disease

The cardiovascular implications of modulating cell specific expression of the serine protease dipeptidyl peptidase-4 (DPP4) were investigated in a series of murine models of metabolic dysfunction-associated steatotic liver disease (MASLD), cardiometabolic disease and myocardial infarction. In vivo experiments were conducted using several genetic models,
openaire   +1 more source

Dipeptidyl-peptidase-4-inhibitors/insulin degludec

Reactions Weekly, 2022
openaire   +1 more source

Dipeptidyl peptidase-4 (DPP-4)

Science-Business eXchange, 2012
openaire   +1 more source

Dipeptidyl-peptidase-4-inhibitors

Reactions Weekly
openaire   +2 more sources

Dipeptidyl-Peptidase-4-Hemmer und Herzinsuffizienz

Der Kardiologe, 2014
I. Vardarli, C. Özcelik
openaire   +1 more source

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

Dipeptidyl peptidase-4 inhibitors/metformin

Reactions Weekly, 2018
openaire   +1 more source